1 | the pure mushroom initiative | | | | | | | 3 | 0.78% |
2 | pure mushroom initiative pure | | | | | | | 2 | 0.52% |
3 | compounds certificate of analysis | | | | | | | 2 | 0.52% |
4 | client rights corporate culture | | | | | | | 2 | 0.52% |
5 | extraction methods testing and | | | | | | | 2 | 0.52% |
6 | farming extraction methods testing | | | | | | 2 | 0.52% |
7 | responsible farming extraction methods | | | | | | 2 | 0.52% |
8 | labelling client rights corporate | | | | | | | 2 | 0.52% |
9 | certificate of analysis super | | | | | | | 2 | 0.52% |
10 | and labelling client rights | | | | | | | 2 | 0.52% |
11 | medicinal compounds certificate of | | | | | | | 2 | 0.52% |
12 | validated assays reputable thirdparty | | | | | | | 1 | 0.26% |
13 | assays reputable thirdparty laboratories | | | | | | | 1 | 0.26% |
14 | and validated assays reputable | | | | | | | 1 | 0.26% |
15 | thirdparty laboratories and full | | | | | | | 1 | 0.26% |
16 | disclosure of results packaginglabelling | | | | | | | 1 | 0.26% |
17 | of results packaginglabelling packaging | | | | | | | 1 | 0.26% |
18 | testingassays precision testing qualified | | | | | | | 1 | 0.26% |
19 | compounds testingassays precision testing | | | | | | | 1 | 0.26% |
20 | all compounds testingassays precision | | | | | | | 1 | 0.26% |
21 | results packaginglabelling packaging must | | | | | | | 1 | 0.26% |
22 | packaginglabelling packaging must protect | | | | | | | 1 | 0.26% |
23 | preserve inform commit deliver | | | | | | | 1 | 0.26% |
24 | of all compounds testingassays | | | | | | | 1 | 0.26% |
25 | retention of all compounds | | | | | | | 1 | 0.26% |
26 | reputable thirdparty laboratories and | | | | | | | 1 | 0.26% |
27 | deliver and above all be safe | | | | | | | 1 | 0.26% |
28 | inform commit deliver and above | | | | | | | 1 | 0.26% |
29 | access to product medicinal | | | | | | | 1 | 0.26% |
30 | are the right of | | | | | | | 1 | 0.26% |
31 | personnel are the right | | | | | | | 1 | 0.26% |
32 | corporate personnel are the | | | | | | | 1 | 0.26% |
33 | to corporate personnel are | | | | | | | 1 | 0.26% |
34 | and to corporate personnel | | | | | | | 1 | 0.26% |
35 | to product medicinal specifics | | | | | | | 1 | 0.26% |
36 | rights access to product | | | | | | | 1 | 0.26% |
37 | commit deliver and above all | | | | | | | 1 | 0.26% |
38 | client rights access to | | | | | | | 1 | 0.26% |
39 | design client rights access | | | | | | | 1 | 0.26% |
40 | functional design client rights | | | | | | | 1 | 0.26% |